Invectys Information

View Top Employees from Invectys

Invectys, Inc. is a privately owned clinical-stage company, headquartered in Houston, Texas, which is developing a new generation of First-in-Class products for cancer patients. Invectys has two wholly owned subsidiaries, Invectys, SAS (Paris) which is focused on scientific research and innovation and Invectys USA, Inc. (Houston) which is directing the clinical development of the Company’s lead HLA-G product. Since 2010, Invectys has raised over $60 million in private funds to develop its two innovative platforms of immunotherapy products which target “universal” tumor antigens.

Website	http://www.invectys.com
Revenue	$7 million
Employees	10 (8 on RocketReach)
Founded	2010
Address	12, Rue Jean-Antoine de Baïf, Paris, Île-de-France 75013, FR
Phone	+1 650-853-8347
Technologies	JavaScript , PHP , Twitter +11 more (view full list)
Industry	Biotechnology, Biopharma, Pharmaceuticals, Healthcare, Health Care, Science and Engineering, Life Science, Pharmaceutical, Therapeutics
Keywords	Cancer Immunotherapy, First In Class Drugs, Oncology Therapeutics, Clinical Stage Biotech, Pharmaceutical Development, New Drug Development, Immuno Oncology, Biopharmaceutical Research, Cancer Treatment, Drug Discovery, Therapeutic Antibodies, Biotechnology, Novel Cancer Therapies, Cancer Research, Targeted Therapies, Clinical Trials, Precision Oncology, Pharmaceutical, Cancer Drugs
Competitors	Daiichi Sankyo Co., Ltd., Medixine, ImmunoGen, Inc., Amgen, Regeneron, Merck Group, Roche, Genentech, Bristol Myers Squibb, Eisai Co., Ltd. +43 more (view full list)
SIC	SIC Code 87 Companies, SIC Code 873 Companies
NAICS	NAICS Code 541714 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies